|
Market Closed -
NYSE
16:00:02 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 9.770 USD | -3.84% |
|
-3.36% | -39.05% |
Company Valuation: Core Laboratories Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,033 | 939.9 | 825.1 | 812.7 | 746.4 | 448.3 | - |
| Change | - | -8.98% | -12.21% | -1.51% | -8.16% | -39.94% | - |
| Enterprise Value (EV) | 1,204 | 1,097 | 973.2 | 919.7 | 746.4 | 448.3 | 448.3 |
| Change | - | -8.87% | -11.28% | -5.5% | -18.84% | -39.94% | 0% |
| P/E | 53.1x | 48.3x | 20.5x | 26.2x | 23.6x | 22.7x | 12.8x |
| PBR | 6.47x | 5.02x | - | - | - | - | - |
| PEG | - | - | 0x | -1.1x | 7.79x | -0.6x | 0.2x |
| Capitalization / Revenue | 2.2x | 1.92x | 1.62x | 1.55x | 1.42x | 0.88x | 0.85x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.88x | 0.85x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 7.5x | 6.5x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 11.2x | 7.97x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 20x | 9.22x |
| FCF Yield | 2.23% | 1.57% | 1.72% | 5.34% | 3.48% | 5% | 10.8% |
| Dividend per Share 2 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Rate of return | 0.18% | 0.2% | 0.23% | 0.23% | 0.25% | 0.41% | 0.41% |
| EPS 2 | 0.42 | 0.42 | 0.86 | 0.66 | 0.68 | 0.43 | 0.765 |
| Distribution rate | 9.52% | 9.52% | 4.65% | 6.06% | 5.88% | 9.3% | 5.23% |
| Net sales 1 | 470.3 | 489.7 | 509.8 | 523.8 | 526.5 | 511.9 | 524.8 |
| EBITDA 1 | 70.81 | 61.98 | 76.96 | 80.2 | 73.34 | 59.79 | 69 |
| EBIT 1 | 52.29 | 44.82 | 61.18 | 65.25 | 58.7 | 39.94 | 56.25 |
| Net income 1 | 19.73 | 19.45 | 40.94 | 31.4 | 31.8 | 19.87 | 35.85 |
| Net Debt | 170.9 | 157 | 148 | 107 | - | - | - |
| Reference price 2 | 22.310 | 20.270 | 17.660 | 17.310 | 16.030 | 9.770 | 9.770 |
| Nbr of stocks (in thousands) | 46,290 | 46,371 | 46,724 | 46,950 | 46,563 | 45,885 | - |
| Announcement Date | 2/2/22 | 2/1/23 | 1/31/24 | 1/29/25 | 2/4/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 22.72x | - | - | 0.41% | 448M | ||
| 31.14x | 15.91x | 22.63x | 0.69% | 719B | ||
| 37.85x | 6.89x | 24.44x | 0.95% | 82.84B | ||
| 22.44x | 4.44x | 9.77x | 0.75% | 64.41B | ||
| -88.02x | 19.35x | 46.7x | -.--% | 50.99B | ||
| 11.03x | 1.47x | 7.54x | 1% | 47.99B | ||
| 45.98x | 1.7x | 9.52x | -.--% | 45.85B | ||
| 19.3x | 3.31x | 7.88x | 1.64% | 30.98B | ||
| 19.71x | 6.04x | 11.61x | -.--% | 25.81B | ||
| 9.72x | 2.57x | 6.2x | -.--% | 24.5B | ||
| Average | 13.19x | 6.85x | 16.26x | 0.54% | 109.23B | |
| Weighted average by Cap. | 24.22x | 12.59x | 20.87x | 0.66% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CLB Stock
- Valuation Core Laboratories Inc.
Select your edition
All financial news and data tailored to specific country editions
















